Sage Grouse
---------------------------------------
'When I got on the bus for my first road game at Duke, I saw that every player was carrying textbooks or laptops. I coached in the SEC for 25 years, and I had never seen that before, not even once.' - David Cutcliffe to Duke alumni in Washington, DC, June 2013
Here's a scary story from the South China Morning Post:
"A new study by one of China’s top scientists has found the ability of the new coronavirus to mutate has been vastly underestimated and different strains may account for different impacts of the disease in various parts of the world."
https://www.scmp.com/news/china/scie...-chinese-study
I don't know enough to judge the study or its implications, except to know that this isn't good. How bad I can't say.
A poster who had been banned from this thread posted something interesting this morning. He was given a serious infraction and his post was deleted because those are the consequences for repeatedly flaunting the rules laid out by the moderators, but I still wanted folks to see his otherwise informative post.
We are now at full capacity production of Covid-19 Tests. We are producing millions of these test kits each week. We already had emergency authorization to use these tests in the US, but have now been granted similar concessions in almost every country across the globe.
We also have several vaccine candidates that are already in the human trial testing faze. We provided a purification solution for one of the most promising vaccine candidates which is an mRNA vaccine. It is undergoing human trials at the U.S. National Institutes of Health, and we are also providing the clinical trials for that effort. For those that don't know, here is some info on what mRNA vaccines are, and why they are important in the fight against infectious disease, and what they could mean for the future for diseases such as cancer. https://www.phgfoundation.org/briefing/rna-vaccines
Also, in partnership with Gilead Sciences, we have almost reached full capacity production of the antiviral drug Remdesivir, which has shown promise for treatment of patients with Covid-19 in small sample sizes.
Help is on the way.
Why are you wasting time here when you could be wasting it by listening to the latest episode of the DBR Podcast?
Interesting article from Reuters about people who recover yet still test positive, weeks or months later. https://www.reuters.com/article/us-h...-idUSKCN2240HI
Does anybody really believe we will be at only 60,000 deaths in the US by August anymore?
Yeah, the UW model is getting a ton of pub. But so far it has generally been underestimating things over the past few weeks. Italy, Spain, and France have all now already exceeded the death tolls that the UW model had previously projected as of a week ago, and are still going strong. So while the model appears to do a decent job of identifying when peaks will arise, it doesn’t appear to handle the “after peak is reached” very well. So it is hard to take the 66,000 projected deaths by August as very likely.
Also worth noting that the estimates assume full social distancing through May 31, which simply isn’t going to happen. Just want to be fair to those researchers as they fully acknowledge that assumption’s limitation.
Also worth noting that it doesn’t consider the second wave problem at all (again, a noted limitation from the authors).
Last edited by CDu; 04-22-2020 at 12:12 PM.
Sage Grouse
---------------------------------------
'When I got on the bus for my first road game at Duke, I saw that every player was carrying textbooks or laptops. I coached in the SEC for 25 years, and I had never seen that before, not even once.' - David Cutcliffe to Duke alumni in Washington, DC, June 2013
That's to be expected given their divergent and highly-criticized strategy. The question is what their per-capita death rate will be compared to their neighbors by the time a vaccine is widely available in 2021. From what I am reading...
... and I thank everyone who has responded, Sweden is a huge underdog but there is a narrow pathway for them to come out ahead of their neighbors.
Essentially:
(1) Sweden's health care system must not be overwhelmed (yes, including staff) during the first wave.
(2) Sweden attains herd immunity before the second wave while their neighbors lag far behind in attaining herd immunity.
(3) Their neighbors' health care system *is* overwhelmed during the second wave of Covid-19 in combination with the flu while Sweden enjoys the benefits of herd immunity and isn't overwhelmed.
As far as I can tell.
I think it is an even bigger underdog scenario than you lay out, actually. Even in that scenario, it's hard to see how they come out ahead.
In order to achieve herd immunity, they'd essentially have to max out on cases in the first wave. That would mean that in order to catch up, their neighbors would have to max out in the second wave. In which case, they'd end up with about the same case load (per capita). Only in those who experience their "maxing out" during the second wave will have the advantage of better prep. Also, the second wave would probably be less impactful because those other countries would be starting from a nonzero point in partial immunity, whereas Sweden is starting from scratch right now.
Basically, it's hard to see how a scenario exists where Sweden would be not overwhelmed by reaching herd immunity during the first wave (in which we don't have good knowledge of the disease nor a good treatment and no prior immunity) but their neighbors would be overwhelmed in the second wave (in which we start with some prior immunity and hopefully are better prepared and hopefully have a treatment).
There were two other ships that docked this week. The Pacific Princess (not the same ship that was the Love Boat) finally docked in LA after ending its around the world tour early. (Most of its passengers got off in Australia, the remainder couldn’t fly home because of other medical reasons.). The MSC Magnifica, which started out from Genoa in January, also on a long tour, finally docked in France.
Sage Grouse
---------------------------------------
'When I got on the bus for my first road game at Duke, I saw that every player was carrying textbooks or laptops. I coached in the SEC for 25 years, and I had never seen that before, not even once.' - David Cutcliffe to Duke alumni in Washington, DC, June 2013
I hope this has not impacted the schedule of the Swedish Bikini Team. We need sports back on television, pronto.
BD80, please re-post your now deleted comment without the obvious political references. Your point about contact tracing and privacy can be made without politics. Thanks!
Why are you wasting time here when you could be wasting it by listening to the latest episode of the DBR Podcast?
There was a really good article by a Harvard professor of exposure and assessment science who made the point that many of the articles about (for example) how the virus can remain on surfaces for days is very misleading...it was linked here and discussed I believe... There is a huge difference between the virus being detectable and transmissible. By and large he made the case that it takes some pretty direct sneezing or coughing on your UPS package to pose much of a threat.
There's a lot of advice now (which we've been following) that a lot of stuff you bring home, or get delivered, can just be set aside for a day or two doing its own quarantine thing...the point being that this can explain why taking in supplies for that ship didn't result in a virus outbreak...in fact, here's the article from WaPo...https://www.washingtonpost.com/opini...ting-packages/
A question for the crowd. I know it has been emphasized again and again that testing is a key element to managing the impact of Covid-19. In an ideal scenario, what does that look like? Who gets tested? What type of test? How many people tested? How often is there follow-up if any?
I ask as I've heard continuous announcements of such and such a company developing a new test that does X, Y, and Z. But it isn't clear to me when these things can actually get to scale to be useful. I am not belittling an entities efforts to get to 1 million test kits produced per month etc., I just have no idea if that is meaningful or inadequate based on the testing regimen. Any thoughts are appreciated!
If it has been answered already, please let me know.